ArticleClinical and translational medicine2022

CD44v6 chimeric antigen receptor T cell specificity towards AML with FLT3 or DNMT3A mutations.

Ling Tang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.